[ET Net News Agency, 3 November 2025] SIMCERE PHARMA (02096) rose 10.1% to HK$13.61.
It hits an intra-day high of HK$13.62, breaking above the 100-D SMA of HK$12.475, and an intra-day low of HK$12.23. The total shares traded was 12.22 million, with a value of HK$159.28m. The active buy/sell ratio is 71:29, with net buying turnover of HK$64.33m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$6.45m, with volume weighted average price of HK$13.056. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$16.97m, with volume weighted average price of HK$13.078. The stock has risen a combined 14.9% over the past 2 consecutive trading days.
Basic Information| Nominal | 13.610 | % Chg | +10.11% |
| High | 13.620 | Low | 12.230 |
| Shares Tr | 12.22m | Turnover | 159.28m |
| 10-D SMA | 12.695 | %H.V | 51.005 |
| 20-D SMA | 12.714 | VWAP | 13.030 |
| 50-D SMA | 13.156 | RSI14 | 58.143 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 71:29, with net buying turnover of HK$64.33m, rising a combined 14.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SIMCERE PHARMA (02096) | 13.61 | +10.11 |
| GRAND PHARMA (00512) | 8.80 | +6.54 |
| CSPC PHARMA (01093) | 7.75 | +1.31 |
| SINO BIOPHARM (01177) | 7.22 | +2.12 |
| HENGRUI PHARMA (01276) | 74.25 | -1.26 |
| 3SBIO (01530) | 31.90 | +3.57 |
| FOSUN PHARMA (02196) | 23.92 | +0.42 |
| WUXI APPTEC (02359) | 105.00 | -3.31 |
| HANSOH PHARMA (03692) | 36.62 | +2.75 |
| UNITED LAB (03933) | 13.01 | +3.50 |
(ed)